Abstract
Purpose of Review
The use of intracameral antibiotics (ICAs) as endophthalmitis prophylaxis after cataract surgery has increased in the past decade. The goal of this paper is to review the current literature arguing for and against ICAs.
Recent Findings
There is compelling evidence that ICAs have greater efficacy than topical antibiotics in preventing post-operative endophthalmitis. However, issues related to availability, cost, and safety have limited their widespread adoption in countries such as the USA.
Summary
In countries without access to a commercially available prepackaged antibiotic for intracameral use, cataract surgeons will have to individually weigh the risks and benefits of ICAs in determining their method of endophthalmitis prophylaxis.
Similar content being viewed by others
References
Garg P, Roy A, Sharma S. Endophthalmitis after cataract surgery: epidemiology, risk factors, and evidence on protection. Curr Opin Ophthalmol. 2017;28(1):67–72. https://doi.org/10.1097/ICU.0000000000000326.
Friling E, Lundstrom M, Stenevi U, Montan P. Six-year incidence of endophthalmitis after cataract surgery: Swedish national study. J Cataract Refract Surg. 2013;39(1):15–21. https://doi.org/10.1016/j.jcrs.2012.10.037.
Grzybowski A, Kanclerz P, Myers WG. The use of povidone-iodine in ophthalmology. Curr Opin Ophthalmol. 2017;29:19–32. https://doi.org/10.1097/ICU.0000000000000437.
Grzybowski A, Kuklo P, Pieczynski J, Beiko G. A review of preoperative manoeuvres for prophylaxis of endophthalmitis in intraocular surgery: topical application of antibiotics, disinfectants, or both? Curr Opin Ophthalmol. 2016;27(1):9–23. https://doi.org/10.1097/ICU.0000000000000216.
Huang J, Wang X, Chen X, Song Q, Liu W, Lu L. Perioperative antibiotics to prevent acute endophthalmitis after ophthalmic surgery: a systematic review and meta-analysis. PLoS One. 2016;11(11):e0166141. https://doi.org/10.1371/journal.pone.0166141.
Balestrazzi A, Malandrini A, Montagnani F, Nguisseu Chegoua GL, Ciompi L, Zanchi A, et al. Phacoemulsificator and sterile drapes contamination during cataract surgery: a microbiological study. Eur J Ophthalmol. 2012;22(2):188–94. https://doi.org/10.5301/EJO.2011.8434.
Endophthalmitis Study Group ESoC. Refractive S. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33(6):978–88. https://doi.org/10.1016/j.jcrs.2007.02.032.
Chang DF, Braga-Mele R, Henderson BA, Mamalis N, Vasavada A, Committee ACC. Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2014 ASCRS member survey. J Cataract Refract Surg. 2015;41(6):1300–5. https://doi.org/10.1016/j.jcrs.2015.01.014.
Barry P. Adoption of intracameral antibiotic prophylaxis of endophthalmitis following cataract surgery: update on the ESCRS Endophthalmitis Study. J Cataract Refract Surg. 2014;40(1):138–42. https://doi.org/10.1016/j.jcrs.2013.11.002.
Herrinton LJ, Shorstein NH, Paschal JF, Liu L, Contreras R, Winthrop KL, et al. Comparative effectiveness of antibiotic prophylaxis in cataract surgery. Ophthalmology. 2016;123(2):287–94. https://doi.org/10.1016/j.ophtha.2015.08.039.
Haripriya A, Chang DF, Namburar S, Smita A, Ravindran RD. Efficacy of intracameral moxifloxacin endophthalmitis prophylaxis at Aravind Eye Hospital. Ophthalmology. 2016;123(2):302–8. https://doi.org/10.1016/j.ophtha.2015.09.037.
Haripriya A, Chang DF, Ravindran RD. Endophthalmitis reduction with intracameral moxifloxacin prophylaxis: analysis of 600 000 surgeries. Ophthalmology. 2017;124(6):768–75. https://doi.org/10.1016/j.ophtha.2017.01.026.
Cao H, Zhang L, Li L, Lo S. Risk factors for acute endophthalmitis following cataract surgery: a systematic review and meta-analysis. PLoS One. 2013;8(8):e71731. https://doi.org/10.1371/journal.pone.0071731.
Kessel L, Flesner P, Andresen J, Erngaard D, Tendal B, Hjortdal J. Antibiotic prevention of postcataract endophthalmitis: a systematic review and meta-analysis. Acta Ophthalmol. 2015;93(4):303–17. https://doi.org/10.1111/aos.12684.
Linertova R, Abreu-Gonzalez R, Garcia-Perez L, Alonso-Plasencia M, Cordoves-Dorta LM, Abreu-Reyes JA, et al. Intracameral cefuroxime and moxifloxacin used as endophthalmitis prophylaxis after cataract surgery: systematic review of effectiveness and cost-effectiveness. Clin Ophthalmol. 2014;8:1515–22. https://doi.org/10.2147/OPTH.S59776.
Naseri A, Melles RB, Shorstein NH. Intracameral antibiotics in the shadow of hemorrhagic occlusive retinal vasculitis. Ophthalmology. 2017;124(5):580–2. https://doi.org/10.1016/j.ophtha.2017.02.019.
Schwartz SG, Grzybowski A, Flynn HW Jr. Antibiotic prophylaxis: different practice patterns within and outside the United States. Clin Ophthalmol. 2016;10:251–6. https://doi.org/10.2147/OPTH.S100429.
Kim SJ, Toma HS. Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections. Ophthalmology. 2011;118(7):1358–63. https://doi.org/10.1016/j.ophtha.2010.12.014.
Braga-Mele R, Chang DF, Henderson BA, Mamalis N, Talley-Rostov A, Vasavada A, et al. Intracameral antibiotics: safety, efficacy, and preparation. J Cataract Refract Surg. 2014;40(12):2134–42. https://doi.org/10.1016/j.jcrs.2014.10.010.
Nicholson LB, Kim BT, Jardon J, Townsend-Pico W, Santos C, Moshfeghi AA, et al. Severe bilateral ischemic retinal vasculitis following cataract surgery. Ophthalmic Surg Lasers Imaging Retina. 2014;45(4):338–42. https://doi.org/10.3928/23258160-20140605-01.
Witkin AJ, Chang DF, Jumper JM, Charles S, Eliott D, Hoffman RS, et al. Vancomycin-associated hemorrhagic occlusive retinal vasculitis: clinical characteristics of 36 eyes. Ophthalmology. 2017;124(5):583–95. https://doi.org/10.1016/j.ophtha.2016.11.042.
Administration USFD. Compounded Triamicinolone and Moxifloxacin Product for Intravitreal Injection by Guardian Pharmacy Services: Alert to Health Professionals - Serious Adverse Events Reported. 2017. https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm569123.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery. Accessed October 24th, 2017.
Administration USFD. A case of hemorrhagic occlusive retinal vasculitis (HORV) following intraocular injections of a compounded triamcinolone, moxifloxacin, and vancomycin formulation. https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompounding/ucm578514.htm. Accessed 7 February 2018.
Todorich B. New Insights in Vancomycin-associated Hemorrhagic Occlusive Retinal Vasculopathy (HORV). Retina Society Annual Meeting; Boston, MA October 5, 2017.
Arshinoff SA, Modabber M. Dose and administration of intracameral moxifloxacin for prophylaxis of postoperative endophthalmitis. J Cataract Refract Surg. 2016;42(12):1730–41. https://doi.org/10.1016/j.jcrs.2016.10.017.
Delyfer MN, Rougier MB, Leoni S, Zhang Q, Dalbon F, Colin J, et al. Ocular toxicity after intracameral injection of very high doses of cefuroxime during cataract surgery. J Cataract Refract Surg. 2011;37(2):271–8. https://doi.org/10.1016/j.jcrs.2010.08.047.
Cakir M, Imamoglu S, Cekic O, Bozkurt E, Alagoz N, Oksuz L, et al. An outbreak of early-onset endophthalmitis caused by Fusarium species following cataract surgery. Curr Eye Res. 2009;34(11):988–95. https://doi.org/10.3109/02713680903254822.
Mamalis N, Edelhauser HF, Dawson DG, Chew J, LeBoyer RM, Werner L. Toxic anterior segment syndrome. J Cataract Refract Surg. 2006;32(2):324–33. https://doi.org/10.1016/j.jcrs.2006.01.065.
Schwartz SG, Flynn HW Jr, Grzybowski A, Relhan N, Ferris FL 3rd. Intracameral antibiotics and cataract surgery: endophthalmitis rates, costs, and stewardship. Ophthalmology. 2016;123(7):1411–3. https://doi.org/10.1016/j.ophtha.2016.03.024.
O'Brien TP, Arshinoff SA, Mah FS. Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin. J Cataract Refract Surg. 2007;33(10):1790–800. https://doi.org/10.1016/j.jcrs.2007.06.026.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Ocular Microbiology and Immunology
Rights and permissions
About this article
Cite this article
Tye, A., Witkin, A.J. The Safety, Efficacy, and Potential Complications of Intracameral Antibiotics. Curr Ophthalmol Rep 6, 152–156 (2018). https://doi.org/10.1007/s40135-018-0174-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40135-018-0174-3